Results 131 to 140 of about 1,525,022 (327)

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

open access: yesMolecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller   +17 more
wiley   +1 more source

Demand Response Unit Commitment Problem Solution for Maximizing Generating Companies’ Profit

open access: yesEnergies, 2017
Over the recent years there has been an immense growth in load consumption due to which, Load Management (LM) has become more significant. Energy providers around the world apply different load management concepts and techniques to improve the load ...
K. Selvakumar   +2 more
doaj   +1 more source

A Minimal Incentive-based Demand Response Program With Self Reported Baseline Mechanism

open access: yes, 2019
In this paper, we propose a novel incentive based Demand Response (DR) program with a self reported baseline mechanism. The System Operator (SO) managing the DR program recruits consumers or aggregators of DR resources.
Baeyens, Enrique   +4 more
core  

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

A Model for Multi-Energy Demand Response with Its Application in Optimal TOU Price

open access: yesEnergies, 2019
With the generalization of the integrated energy system (IES) on the demand side, multi-energy users may participate in a demand response (DR) program based on their flexible consumption of energy.
Nan Zhao, Beibei Wang, Mingshen Wang
doaj   +1 more source

Ventajas de la gestión activa de la demanda (Demand management) en el control de Smart-grids [PDF]

open access: yes, 2018
La gestión del sistema eléctrico por las utilities se ve afectado por varios factores, como un aumento del consumo, una mayor penetración de las energías renovables y la tendencia a la generación distribuida (para minimizar pérdidas asociadas al ...
Beltrán, Ana M. (Coordinador)   +5 more
core  

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

A Day-ahead and Day-in Decision Model Considering the Uncertainty of Multiple Kinds of Demand Response

open access: yesEnergies, 2019
The uncertainty of demand response (DR) will affect the economics of power grid dispatch due to the randomness of participating users’ intentions.
Siqing Sheng, Qing Gu
doaj   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Correlation of the differential expression of PIK3R1 and its spliced variant, p55α, in pan‐cancer

open access: yesMolecular Oncology, EarlyView.
PIK3R1 undergoes alternative splicing to generate the isoforms, p85α and p55α. By combining large patient datasets with laboratory experiments, we show that PIK3R1 spliced variants shape cancer behavior. While tumors lose the protective p85α isoform, p55α is overexpressed, changes linked to poorer survival and more pronounced in African American ...
Ishita Gupta   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy